Clinical Trial

A Study to Evaluate ALN-4915 in Adult Healthy Volunteers

Name: A Study to Evaluate ALN-4915 in Adult Healthy Volunteers — clinical trial record (NCT07535606)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

The purpose of this study is to evaluate the safety, tolerability, pharmacodynamics (PD) and pharmacokinetics (PK) of ALN-4915.

Protocol Amendment History 3 amendments

This ClinicalTrials.gov record has been amended 3 times since 2026-04-10; most recent amendment 2026-07-22.

Trial Details

NCT Number	NCT07535606
Lead Sponsor	Alnylam Pharmaceuticals
Conditions	Healthy Volunteers
Enrollment	44 participants
Start Date	2026-03-02
Primary Completion	2027-07-31 (estimated)
Study Completion	2027-07-31 (estimated)
Updated on ClinicalTrials.gov	2026-08-12